Analyst consensus rating
Greenwich LifeSciences Analyst Rating: none
Direct answer
Greenwich LifeSciences's consensus rating is none.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $57.00.
Forecast evidence checked November 16, 2026.
Get free Greenwich LifeSciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $14.94
- Average price target
- $57.00
- High price target
- $69.00
- Low price target
- $45.00
- Low target gap
- +201.2%
- Target upside
- +281.5%
- High target gap
- +361.8%
- Target range width
- 160.6%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- November 16, 2026
- Valid through
- November 23, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Greenwich LifeSciences?
Greenwich LifeSciences has a verified none consensus. The same dataset has an average price target of $57.00.
How far are Greenwich LifeSciences's low and high targets from the recorded price?
The low target implies +201.2%, while the high target implies +361.8%.
How many analysts are included in Greenwich LifeSciences's consensus?
The verified consensus includes 2 analysts.
How is Greenwich LifeSciences's target upside or downside calculated?
The average target of $57.00 is divided by the recorded price of $14.94, then one is subtracted to produce +281.5%. This does not guarantee a future return.
When was Greenwich LifeSciences's analyst forecast verified?
The data was verified on 2026-11-16. The dataset is valid through 2026-11-23.